Hanne Leth Hillman
Chairman at The Danish Investor Relations Society
Hanne Leth Hillman active positions
Companies | Position | Start | End |
---|---|---|---|
The Danish Investor Relations Society | Chairman | - | - |
Director/Board Member | - | - | |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Director of Finance/CFO | 2017-04-30 | - |
Career history of Hanne Leth Hillman
Former positions of Hanne Leth Hillman
Companies | Position | Start | End |
---|---|---|---|
BRAIN+ A/S | Director/Board Member | 2021-04-30 | 2023-12-31 |
Director of Finance/CFO | 2022-08-31 | 2023-12-31 | |
Independent Dir/Board Member | 2021-04-30 | 2022-08-31 | |
ZEALAND PHARMA A/S | Investor Relations Contact | 2010-12-31 | 2016-09-30 |
Public Communications Contact | 2010-12-31 | 2016-09-30 | |
Gudme Raaschou Bank A/S | Analyst-Equity | 2004-11-04 | 2004-11-04 |
NTG NORDIC TRANSPORT GROUP A/S | Investor Relations Contact | - | - |
Public Communications Contact | 2009-08-27 | - |
Training of Hanne Leth Hillman
University of Aarhus | Masters Business Admin |
Statistics
International
Denmark | 8 |
Operational
Investor Relations Contact | 2 |
Public Communications Contact | 2 |
Director/Board Member | 2 |
Sectoral
Health Technology | 3 |
Transportation | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
NTG NORDIC TRANSPORT GROUP A/S | Transportation |
ZEALAND PHARMA A/S | Health Technology |
BRAIN+ A/S | Technology Services |
Private companies | 3 |
---|---|
Gudme Raaschou Bank A/S | Finance |
The Danish Investor Relations Society | |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
- Stock Market
- Insiders
- Hanne Leth Hillman
- Experience